Kvam TM

DPS Nord, Østfold Hospital Trust, Grålum, Norway.

11 papers · ORCID

Clinical and non-clinical use of MDMA.

Kvam TM, Goksøyr IW, Stewart LH +3

MDMA-assisted psychotherapy in major depression: critical considerations for clinical translation: commentary, Kvam et al.

Kvam TM, Goksøyr IW, Rog J +3

MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study - CORRIGENDUM.

Kvam TM, Goksøyr IW, Rog J +8

MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial.

Kvam TM, Goksøyr IW, Rog J +9

Recreational MDMA use in Norway: results from an internet convenience sample.

Grønnerød C, Rønningen T, Haugsjå IR +3

MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study.

Kvam TM, Goksøyr IW, Rog J +8

ArticlePsilocybin

Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire.

Andersen KAA, Holmøy B, Kvam TM +1

ArticlePsilocybin

Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.

Tunstad PA, Kvam TM, Uthaug MV +3

ArticlePsilocybin

Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.

Kvam TM, Uthaug MV, Andersen KAA +5

Study protocol for "MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study".

Kvam TM, Goksøyr IW, Stewart LH +3

ArticlePsilocybin

Psychedelic drugs in the treatment of anxiety, depression and addiction.

Kvam TM, Stewart LH, Andreassen OA